Blood transfusions have long been the go-to procedure for replenishing red blood cells and oxygen delivery in patients who have experienced significant blood loss. However, natural substitutes are already being developed to mimic the positive effects of transfusions while minimising concerns like infections and incompatibilities. Here, we’ll look at several interesting new options and explain why we should give them some thought.
A Synopsis of Blood Transfusion History
The contemporary era of successful blood transfusions began in the early 1900s with the discovery of blood types and cross-matching, despite centuries of trials with animal-human blood exchanging. By the middle of the 20th century, transfusions were common medical procedures for replenishing blood and treating disorders thanks to blood banking, screening, and component separation.
However, transfusions also included hazards such as bacterial infection, virus contamination, and severe hemolytic reactions. Interest in non-donor alternatives employing synthetic or purified molecules that replicate the oxygen supply of red blood cells without the attendant hazards has grown as a result of the desire to prevent such issues.
Click here for natural alternatives to blood transfusion.
Oxygen-Based Haemoglobin Carriers (HBOCs)
One of the most popular alternatives employs solutions of stabilised haemoglobin proteins derived from people, cows, or genetically altered bacteria. These perform the same role as native haemoglobin does as oxygen carriers. In contrast to regular haemoglobin, HBOCs defy renal filtration by remaining stable when present outside of red blood cells in free form.
To prevent the toxicity problems that plagued earlier versions, researchers have sought to optimise haemoglobin purity, molecular structure, and encapsulation in protective shells. HBOCs currently show potential in swiftly restoring oxygenation without restrictions on blood types or preservation requirements. There are more trials going on. They might support or take the place of transfusions if they are shown to be safe and effective.
PFCs, or perfluorocarbons
PFCs are artificial liquid substances that have a high oxygen and carbon dioxide transport capacity without affecting blood constituents. They are biologically stable because they are inert. First-generation PFCs remained in the body for too long despite being promising. As a result, the substance is exhaled after usage in newer PFC formulations that diminish persistence.
PFCs may soon provide transient oxygenation after surgery or life-threatening injuries with improved ventilation strategies to speed exhalation. Due to their universal compatibility and approval for lung lavage treatments, PFCs may replace transfusions in more applications.
Therapy Using Stem Cells
A new method for producing red blood cells that are unique to a patient without donations is made possible by stem cell therapies. Red blood cells that deliver oxygen have been grown effectively using hematopoietic stem cells from bone marrow. With further cell line and growth factor optimisation, this source of transfusion-grade red blood cells might soon become renewable.
Blood Management for Patients (PBM)
Finally, patient blood management (PBM) makes use of medical products, surgical methods, and equipment to enable scheduled operations with a minimum amount of transfusions. While erythropoietin encourages red blood cell synthesis prior to surgery, transexamic acid controls bleeding. Systems for cell salvage replenish lost blood during procedures. Transfusions become a last resort when PBM is present.
The Lesson
While alternatives to transfusions have benefits like universal applicability and decreased infection risk, transfusions still save lives. As research advances, we get a little bit closer to solutions that offer transfusion benefits without requiring donors. Until then, doctors can safely avoid allogeneic transfusions by using PBM techniques. Future developments will go beyond whole blood alone.